Vertex Pharmaceuticals Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VRTX | KRYS | ROIV | ARGX | ALNY | BBIO | |
|---|---|---|---|---|---|---|
| Market cap | 128.50B | 9.83B | 24.99B | 51.08B | 30.38B | 12.85B |
| P/E (TTM) | 29.5 | 41.6 | — | 31.0 | 38.3 | — |
| Forward P/E | 25.1 | 35.8 | -20.1 | 22.8 | 18.3 | 2,275.1 |
| Price/book | 6.3 | 7.2 | 5.9 | 150.9 | 22.4 | -5.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +25.21% | +79.50% | +118.63% | −0.08% | −51.17% | +16.37% |
| Today | −0.60% | +0.14% | −2.40% | −1.54% | −2.43% | +0.61% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VRTX news ›Vertex Pharmaceuticals (VRTX) Reports Promising ALYFTREK Study Results in Young Children with Cystic Fibrosis
What is VRTX's GF Score™? VRTX’s GF Score™ is 87 out of 100, indicating a high-quality company with strong financial strength, profitability, and valuation metrics, though momentum is relatively weaker. Is VRTX overvalued or undervalued?…
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Vertex Pharmaceuticals maintains a dominant, highly profitable position in the global cystic fibrosis market. Which biotechnology stock offers the best balance of clinical potential and financial stability for your portfolio? CRISPR…
Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From It
Vertex Built The NaV1.8 Market, Latigo Stock May Be One To Profit From It (NASDAQ:LTGO) Seeking Alpha - Latigo Biotherapeutics is undervalued below IPO, with onzotrigine showing superior efficacy to Vertex’s Journavx in acute pain. - LTGO…
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
The VanEck Biotech ETF (BBH +2.75%) offers concentrated exposure to large-cap biotech leaders, while the State Street SPDR S&P Pharmaceuticals ETF (XPH +1.60%) provides broader, more diversified access to the pharmaceutical industry.…
Reviewing Vertex Pharmaceuticals (NASDAQ:VRTX) and Caribou Biosciences (NASDAQ:CRBU)
Posted by Sarita Garza on Oct 8th, 2026 Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the…
Vertex Pharmaceuticals Incorporated: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Vertex Pharmaceuticals Incorporated on MarketScreener. Press Releases Vertex Pharmaceuticals Incorporated All financial news and data tailored to specific country editions
All Transcripts on Vertex Pharmaceuticals Incorporated (VRTX)
Find all the latest transcripts on Vertex Pharmaceuticals Incorporated Transcripts Vertex Pharmaceuticals Incorporated All financial news and data tailored to specific country editions
Vertex Pharmaceuticals Incorporated: Latest Headlines - Nasdaq Stock Exchange
Find the latest highlights on Vertex Pharmaceuticals Incorporated at the Nasdaq stock exchange. Highlights Vertex Pharmaceuticals Incorporated All financial news and data tailored to specific country editions
Vertex Pharmaceuticals Incorporated: Relative Strength Chart - Stock Nasdaq
Compare Vertex Pharmaceuticals Incorporated with the company of your choice via a Relative Strength chart. Real-time VRTX price, Nasdaq stock exchange Relative Strength Chart Vertex Pharmaceuticals Incorporated All financial news and data…
Vertex Pharmaceuticals Incorporated: News in other languages | VRTX | US92532F1003
Vertex Pharmaceuticals Incorporated: News, information and stories for Vertex Pharmaceuticals Incorporated | Nasdaq: VRTX | Nasdaq Other languages Vertex Pharmaceuticals Incorporated All financial news and data tailored to specific country…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com14
-
theglobeandmail.com5
-
fool.com4
-
defenseworld.net2
-
gurufocus.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 42 articles, not a forecast.